Insights from Bayer’s $1.5 Billion VC Fund

Insights from Bayer’s $1.5 Billion VC Fund

Discover how Bayer's Leaps Venture Capital arm is transforming the biotech landscape by investing in cutting-edge therapies and technologies. Lucio Iannone, a leading investor at Leaps, shares insights into their unique approach and the future of healthcare.

More Episodes

Listen on:

Youtube icon link

Spotify icon link

Apple Podcasts icon link

Unlocking Female Longevity: Redefining Menopause as a Choice

Dr. Piraye Yurttas Beim, a molecular biologist and entrepreneur, is revolutionizing women's health through her groundbreaking work at...

Unlocking the Immune System to Combat Aging

Deciduous CEO Robin Mansukhani discusses how their company is working on harnessing the immune system to treat diseases of aging. Robin...

Convergence of CRISPR and Stem Cells is Changing Regenerative Medicine

Join Dr. Faizzan Ahmad, CEO of Cure8bio, as he explores the frontier of regenerative medicine. From his journey at Oxford to pioneering a...

Regenerative Medicine, the Future of Healthcare

Discover how Yaky Yanay, CEO of Pluri, is revolutionizing regenerative medicine using placenta-derived cells. From combating radiation...

Unique Longevity Investing Advice From the World's Most Misunderstood Biohacker ($2M/yr)

Join Jess Larsen and co-host Greg Bailey as they welcome biohacking legend Bryan Johnson to explore the frontiers of health and longevity.

Investing in Life-Changing Therapies

Lucio Iannone, VP of Venture Investments at Leaps by Bayer, shares insights on the future of biotech investment, focusing on cell therapy...

Investing & Lifestyle Principles with Longevity VC

Gain crucial insights into the world of longevity investing with José Navarro-Betancourt—learn the keys to identifying promising biotech...

We Asked the Expert How Aaron Rodgers Had One of the World's Fastest Injury Recoveries

Discover how Aaron Alexander helped NFL star Aaron Rodgers achieve the fastest Achilles tendon rupture recovery ever using techniques...

Advice from One of the World’s Top Longevity Scientists

The field of aging research is undergoing a revolution, and the Buck Institute is at the forefront of this transformative movement. In...

Harvard Professor Dr. Jeff Karp Whose Multiple Companies Have Raised over $600M on His New Book LIT

In this insightful podcast episode, Dr. Jeff Karp shares powerful strategies to tap into your brain's neuroplasticity and rewire it for...

How Could a New Longevity Medicine Create $200B Per Year in Revenue?

What can we learn from an investor who has deployed over $100 million into longevity-focused biotech startups? Alex Colville...

What This Longevity Investor Knows That You Don't

Discover the immense potential of the longevity biotech field with insights from biotech investor Karl Pfleger.

What Ketone Therapeutics Can Really Do

The Buck Institute, a pioneer in aging research, is uncovering how ketones impact healthspan. Dr. Brianna Stubbs, a world-champion...

Longevity for Investors: Big Returns + Longer Life

Join Jess Larsen and guest Greg Bailey in an insightful episode on "Longevity for Investors." Learn about transforming health and...

Can You Reduce Biological Aging? We Ask an Expert

Raising money for longevity research can be a daunting task, especially for founders without a traditional biotech background. Akshay...